Your browser doesn't support javascript.
loading
Annotation and evaluation of base editing outcomes in multiple cell types using CRISPRbase.
Fan, Jibiao; Shi, Leisheng; Liu, Qi; Zhu, Zhipeng; Wang, Fan; Song, Runxian; Su, Jimeng; Zhou, Degui; Chen, Xiao; Li, Kailong; Xue, Lixiang; Sun, Lichao; Mao, Fengbiao.
Afiliação
  • Fan J; Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.
  • Shi L; College of Animal Science and Technology, Yangzhou University, Yangzhou, Jiangsu Province 225009, China.
  • Liu Q; Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.
  • Zhu Z; Cancer Center, Peking University Third Hospital, Beijing 100191, China.
  • Wang F; Rice Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.
  • Song R; Guangdong Key Laboratory of New Technology in Rice Breeding, Guangzhou 510640, China.
  • Su J; Guangdong Rice Engineering Laboratory, Guangzhou 510640, China.
  • Zhou D; Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.
  • Chen X; Cancer Center, Peking University Third Hospital, Beijing 100191, China.
  • Li K; College of Animal Science and Technology, Yangzhou University, Yangzhou, Jiangsu Province 225009, China.
  • Xue L; Rice Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.
  • Sun L; State Key Laboratory of Tree Genetics and Breeding, Forestry College, Northeast Forestry University, Harbin 150040, China.
  • Mao F; College of Animal Science and Technology, Yangzhou University, Yangzhou, Jiangsu Province 225009, China.
Nucleic Acids Res ; 51(D1): D1249-D1256, 2023 01 06.
Article em En | MEDLINE | ID: mdl-36350608
ABSTRACT
CRISPR-Cas base editing (BE) system is a powerful tool to expand the scope and efficiency of genome editing with single-nucleotide resolution. The editing efficiency, product purity, and off-target effect differ among various BE systems. Herein, we developed CRISPRbase (http//crisprbase.maolab.org), by integrating 1 252 935 records of base editing outcomes in more than 50 cell types from 17 species. CRISPRbase helps to evaluate the putative editing precision of different BE systems by integrating multiple annotations, functional predictions and a blasting system for single-guide RNA sequences. We systematically assessed the editing window, editing efficiency and product purity of various BE systems. Intensive efforts were focused on increasing the editing efficiency and product purity of base editors since the byproduct could be detrimental in certain applications. Remarkably, more than half of cancer-related off-target mutations were non-synonymous and extremely damaging to protein functions in most common tumor types. Luckily, most of these cancer-related mutations were passenger mutations (4840/5703, 84.87%) rather than cancer driver mutations (863/5703, 15.13%), indicating a weak effect of off-target mutations on carcinogenesis. In summary, CRISPRbase is a powerful and convenient tool to study the outcomes of different base editors and help researchers choose appropriate BE designs for functional studies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Edição de Genes / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Edição de Genes / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article